Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to perform a randomized controlled study to compare patients undergoing THA via a posterolateral approach to receive either standard of care post-surgery hip restrictions or to receive no restrictions. The investigators goal is to first complete a pilot study in which the investigators assess the short term dislocation rates 3-6 months and then continue to recruit into this study and follow these patients for a year to determine the 1 year risk for dislocation. The investigators also will compare the HOOS Jr. and VAS scores and time until free from walking aid. The research question is: Will the elimination of post operative posterior hip precautions increase the dislocation rate? The hypothesis is that the elimination of post operative hip precautions will not increase the dislocation rate.


Clinical Trial Description

1. Participants at the following institutions (West Virginia University; The Andrews Institute; and University of Kentucky Healthcare Sports Medicine will be given an educational session regarding hip replacement and procedures to follow after total hip replacement at their History and Physical visit prior to elective total hip replacement surgery via a posterior approach. 2. Participants will be told of the study after their educational session. All their questions will be answered and they will be given the opportunity to consent for participation. 3. After consent, the participant will be randomized to a control group receiving Standard of Care (education) hip precautions or to a 'no hip precautions' group. The control group will be instructed to practice postoperative hip precautions they learned at their educational session; (standard of care) (no flexion > 90 degrees, no internal rotation, no adduction) for 6 weeks. The intervention group will be aware of the precautions but will be told not to practice them post-operatively. 4. The participants will be monitored per the surgeons' normal routine post-operatively, which includes notification to the surgeon if the subject returns to the hospital with any hip problems. 5. After the first three participants who were randomized to 'no precautions' have returned for their post-op visit at all sites, the DSMB will have a teleconference to discuss any adverse events including dislocations. If any of the first 3 participants dislocated the study will be stopped. 6. At six weeks the following will be recorded: time to elimination of walking aids, dislocation episodes requiring closed reduction, and need for revision surgery. If any of the first 3 intervention participants dislocated during the 6 week period, the study will be stopped. 7. The participants will be asked to complete the HOOS Jr. and VAS follow-up questions at 2-week, 6-week, 3 month, 6 month and one year post-operatively per standard of care follow-up. Participants will be asked to list any hip precautions practiced at these time frames. 8. If the participants fail to come for the standard of care follow up appointments, the research assistant will call the participants and ask the HOOS Jr. and VAS questionnaires over the phone and to list any hip precautions they practiced. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03341442
Study type Interventional
Source West Virginia University
Contact
Status Completed
Phase N/A
Start date April 2016
Completion date June 2020

See also
  Status Clinical Trial Phase
Completed NCT02405104 - Chlorzoxazone in Hip and Knee Arthroplasty Phase 4
Completed NCT02162186 - Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
Active, not recruiting NCT02263209 - Investigation to Determine Safety of Taperloc Stems With BioGuard Coating When Used in Cementless Total Hip Arthroplasty N/A
Completed NCT02577822 - The Viability of Short Stems in Total Hip Arthroplasty N/A
Active, not recruiting NCT00551967 - Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary THA Using RSA N/A
Active, not recruiting NCT00545285 - Long-Term Multi-center Evaluation of E-Poly and Regenerex N/A
Completed NCT03966573 - Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints N/A
Recruiting NCT04754087 - G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study N/A
Completed NCT00957970 - Bone Mineral Changes Around Stemless and Stemmed Cementless Femoral Components Phase 4
Completed NCT00565786 - ArCom® and ArComXL® Polyethylene Data Collection
Completed NCT03428893 - Mobile Technology to Support Physical Therapy Exercise N/A
Completed NCT01972594 - Pedometer Based Intervention After Total Hip Replacement-A Pilot Study N/A
Terminated NCT02161484 - Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement N/A
Withdrawn NCT01668160 - Stability of Revision Total Hip Arthroplasty Implants Using Radiostereometric Analysis N/A
Not yet recruiting NCT01040273 - Management of Postoperative Pain After Total Hip Arthroplasty Phase 2/Phase 3
Recruiting NCT02836262 - Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty N/A